Search Results

Bard's Flair Stent Graft Bests Balloon Angioplasty in Study

February 10, 2010—Bard Peripheral Vascular, Inc. (Tempe, AZ) announced that Ziv J. Haskal, MD, et al published trial results in the New England Journal of Medicine (NEJM) showing that the Bard Flair endovascular stent graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone (2010;362:494–503). The Flair device has been approved by the US Food and Drug Administration for use in treating stenoses at the venous anastomosis of expanded polytetrafluoroethylene or other synthetic arteriovenous access grafts. In an accompanying editorial in NEJM, “Fistula First, Stent Graft Second,” Robert K. Kerlan, Jr, MD, and Jeanne M. LaBerge, MD, further discuss the Flair investigators' findings and their implications (2010;362:550–552).

Bard’s Flair Stent Graft Demonstrates Superiority to Balloon Angioplasty for Failing Dialysis Grafts

February 10, 2010—Bard Peripheral Vascular, Inc. (Tempe, AZ) announced that Ziv J. Haskal, MD, et al published trial results in the New England Journal of Medicine (NEJM) showing that the Bard Flair endovascular stent graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone (2010;362:494–503). The Flair device has been approved by the US Food and Drug Administration for use in treating stenoses at the venous anastomosis of expanded polytetrafluoroethylene or other synthetic arteriovenous access grafts. In an accompanying editorial in NEJM, "Fistula First, Stent Graft Second," Robert K. Kerlan, Jr, MD, and Jeanne M. LaBerge, MD, further discuss the Flair investigators’ findings and their implications (2010;362:550–552).

Two-Year RENOVA Results Compare Stent Graft Versus PTA to Treat Arteriovenous Graft Anastomotic Stenosis

July 7, 2016—The final 2-year results of the RENOVA study were published by Ziv J. Haskal, MD, et al online ahead of print in the Journal of Vascular and Interventional Radiology (JVIR).

Virtual Reality Training Method for Interventional Radiology Highlighted at SIR 2018

March 21, 2018—The Society of Interventional Radiology (SIR) announced the debut the first-ever virtual reality 360 (VR360) training video showcasing interventional radiology in practice at the SIR 2018 annual scientific meeting held March 17–22 in Los Angeles, California.

FDA Expands Indication for CeloNova's Oncozene and Embozene Microspheres to Treat Liver Cancer

September 3, 2014—CeloNova BioSciences, Inc., announced US Food and Drug Administration (FDA) 510(k) clearance expanding the indication for their Oncozene and Embozene microsphere products to now include the embolization of hepatoma (hepatocellular carcinoma).

SIR Panel Addresses Research Needs for Interventional Treatment of CCSVI in MS Patients

June 16, 2011—The Society of Interventional Radiology (SIR) announced the publication of proceedings from a multidisciplinary research consensus panel that was charged with developing a research agenda for evaluating imaging and interventional therapies for chronic cerebrospinal venous insufficiency (CCSVI) in patients with multiple sclerosis (MS).

RENOVA Results Support Stenting to Improve Access for Dialysis Patients

April 15, 2013—The Society of Interventional Radiology (SIR) announced that 12-month data from the RENOVA trial indicate that kidney failure patients on dialysis derive long-term benefit from the minimally invasive placement of a stent that improves the function of dialysis access grafts.

NextBioMedical Receives IDE Approval for Pivotal Trial of Nexsphere-F Genicular Artery Embolization Device

January 15, 2025—NextBioMedical Co., Ltd., which is based in South Korea, announced that it has received investigational device exemption (IDE) approval from the FDA for its RESORB clinical trial of the company’s Nexsphere-F.

BD’s Liverty TIPS Device for Treatment of Portal Hypertension to Be Studied in ARCH

August 10, 2023—BD (Becton, Dickinson and Company) announced the enrollment of the first patient in ARCH, an investigational device exemption study assessing the safety and effectiveness of the BD Liverty transjugular intrahepatic portosystemic shunt (TIPS) stent graft for the treatment of complications from portal hypertension.

Pioneering Interventional Radiologist João Martins Pisco Has Passed Away

March 28, 2019—The global interventional radiology community is deeply saddened by the sudden passing of João Martins Pisco, MD, PhD, of Lisbon, Portugal on March 26, 2019.